CPTCF (Cytophage Technologies) Long-Term Debt : $0.00 Mil (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Cytophage Technologies Long-Term Debt?

Cytophage Technologies's Long-Term Debt for the quarter that ended in Sep. 2024 was $0.00 Mil.

Cytophage Technologies Long-Term Debt Historical Data

The historical data trend for Cytophage Technologies's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytophage Technologies Long-Term Debt Chart

Cytophage Technologies Annual Data

Trend

Dec21

Dec22

Dec23

Long-Term Debt

Cytophage Technologies Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Long-Term Debt	Get a 7-Day Free Trial					-	-	-	-	-

Cytophage Technologies (GREY:CPTCF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Cytophage Technologies Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Cytophage Technologies's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Cytophage Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytophage Technologies Ltd (GREY:CPTCF) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

CYTO:Canada

Address

26 Henlow Bay, Winnipeg, MB, CAN, R3Y 1G4

Website

https://www.cytophage.com

Cytophage Technologies Ltd is a Canadian biotechnology company that uses molecular genetic techniques and synthetic biology to create effective bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria company generates phages to address specific bacterial infections, including strains resistant to antibiotics. It has also developed a 'phage-display' methodology to develop vaccine-like products using bacteriophages for a number of potential applications in human and animal health.